Home › Heart Attack › Michigan › Detroit
Heart Attack clinical trials in Detroit, MI
4 studies for Heart Attack are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Henry Ford Hospital, Detroit
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Henry Ford Health System, Detroit
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RecruitingObservational studyHealthy volunteers welcome
- Henry Ford Hospital, Detroit
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RecruitingPhase 3
- Henry Ford Health System, Detroit
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- Dallas, TX6 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Knoxville, TN4 studies
- Houston, TX4 studies
- Hartford, CT4 studies
- Boca Raton, FL4 studies
- Los Angeles, CA4 studies
- Raleigh, NC3 studies
- Durham, NC3 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.